| Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib (NCT06620835) | Groupe Francais De Pneumo-Cancerologie | 2025-06-19 |
| Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion (NCT06247826) | Groupe Francais De Pneumo-Cancerologie | 2024-01-15 |
| Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) (NCT05308966) | Groupe Francais De Pneumo-Cancerologie | 2022-05-03 |
| Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC (NCT05122806) | Groupe Francais De Pneumo-Cancerologie | 2021-09-22 |
| Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE) (NCT05049044) | Groupe Francais De Pneumo-Cancerologie | 2020-12-18 |
| Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) (NCT03305133) | Groupe Francais De Pneumo-Cancerologie | 2017-09-26 |
| Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression. (NCT02785562) | Groupe Francais De Pneumo-Cancerologie | 2016-07-21 |
| Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) (NCT02293733) | Groupe Francais De Pneumo-Cancerologie | 2014-01-01 |
| Feasibility of re Biopsies at Progression (NCT02086071) | Groupe Francais De Pneumo-Cancerologie | 2012-05-01 |
| Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer (NCT01956331) | Groupe Francais De Pneumo-Cancerologie | 2009-03-01 |
| Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) (NCT00419042) | Groupe Francais De Pneumo-Cancerologie | 2006-07-01 |
| Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) (NCT00418704) | Groupe Francais De Pneumo-Cancerologie | 2006-05-01 |
| Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC) (NCT00418743) | Groupe Francais De Pneumo-Cancerologie | 2005-12-01 |